Safety and Efficacy of KER-065 in Participants With Duchenne Muscular Dystrophy
Clinical trial NCT07704099 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07704099
- Sponsor
- Keros Therapeutics, Inc.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-09-14
- Primary completion
- 2029-07-17
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.